USPTO 2015–2025 USPTO PatentsView US Corporation

Translate BIO, Inc.

USPTO PatentsView assignee record - 132 granted patents across 22 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

132

Total patents granted

CPC technology areas

16.1

Avg claims per patent

+177%

5-year filing velocity

The verdict

Translate holds 132 US patents across 22 technology areas, rank #2,904 of 50,000 tracked assignees.

#2,904
of 50,000 US assignees by volume: Top 15%
by Innovation Score (49.0/100): 16.1
avg claims per patent: +177%
filing velocity, last 5 yrs

Portfolio overview

Translate BIO, Inc. has been granted 132 US utility patents between 2017 and 2025, placing Translate BIO, Inc. at rank #2,904 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Translate BIO, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Translate sits between Nippon Paper Industries Co., Ltd. (132 patents, rank #2,900) and Ashley Furniture Industries, Llc (131 patents, rank #2,908) - the closest US assignees by grant volume. The composite Innovation Score of 49.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 97 grants, compared with 35 in the 2015–2019 window, a +177% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Translate BIO, Inc.'s 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Translate BIO, Inc. against peers pursuing similar technology classes.

Nippon Paper Indu…

132
Prince Mohammad B…

132
Regalo Internatio…

132
Space Exploration

132
Trinity Bay Equip…

132
Werner

132
Westrock Packagin…

132
Translate BIO ◀

132
Ashley Furniture…

131

What this shows Translate holds 132 patents at rank #2,904, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Translate

By rank, the assignees closest to #2,904 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Translate's primary technology class.

Translate's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Translate BIO, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	0.8%
2018	16	12.1%
2019	18	13.6%
2020	14	10.6%
2021	21	15.9%
2022	16	12.1%
2023	8	6.1%
2024	23	17.4%
2025	15	11.4%

Which technologies does Translate BIO, Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 103

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 100

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 78

C12Y - ENZYMES 67

C07K - PEPTIDES 39

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 27

C07D - HETEROCYCLIC COMPOUNDS 17

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 15

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 13

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 9

C07J - STEROIDS 7

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 4

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3

B01D - SEPARATION 2

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 2

Top 15 of 22 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#2,904

Across all tracked assignees

Innovation Score

49.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Translate BIO, Inc. hold?

Translate BIO, Inc. holds 132 US granted patents filed between 2017 and 2025, spanning 22 technology areas.

What is Translate BIO, Inc.'s Innovation Score?

Translate BIO, Inc. has an Innovation Score of 49.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Translate BIO, Inc. focus on?

Translate BIO, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 103 patents. The company has filed patents in 22 CPC subclasses total.

Is Translate BIO, Inc.'s patent filing rate increasing or decreasing?

Translate BIO, Inc.'s recent filing velocity is +177% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Translate BIO, Inc.'s patents?

Translate BIO, Inc.'s patents average 16.1 claims each. This falls within the standard range, providing solid legal coverage.

How is the Translate BIO, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Translate's 132 grants land it in the top 15% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Translate ranks #2,904 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.